• 09 – A New Era of GVHD Prevention Post-HCT, Pt. 1: PTCy and Improved Outcomes

  • 2023/11/27
  • 再生時間： 34 分
  • ポッドキャスト

09 – A New Era of GVHD Prevention Post-HCT, Pt. 1: PTCy and Improved Outcomes

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • In this two-part episode, Javier Bolaños-Meade, MD, with the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Shernan Holtan, MD, with the University of Minnesota discuss advances and innovations in graft-versus-host disease (GVHD) prevention that call for a new standard of care in patients needing allogeneic hematopoietic cell transplantation.

    In Part I: PTCy and Improved Outcomes, experts highlight the history of GVHD prevention and the impacts of post-transplant cyclophosphamide (PTCy) in particular in improving outcomes and closing gaps in access to care.

    To read bios on the panelists and to access additional resources related to this episode, visit Our Site.

    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

In this two-part episode, Javier Bolaños-Meade, MD, with the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Shernan Holtan, MD, with the University of Minnesota discuss advances and innovations in graft-versus-host disease (GVHD) prevention that call for a new standard of care in patients needing allogeneic hematopoietic cell transplantation.

In Part I: PTCy and Improved Outcomes, experts highlight the history of GVHD prevention and the impacts of post-transplant cyclophosphamide (PTCy) in particular in improving outcomes and closing gaps in access to care.

To read bios on the panelists and to access additional resources related to this episode, visit Our Site.

身体的病い・疾患 衛生・健康的な生活
続きを読む 一部表示

09 – A New Era of GVHD Prevention Post-HCT, Pt. 1: PTCy and Improved Outcomesに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。